BCL2 and in situ carcinoma: Conversely, the expression of Bcl-2 (anti-apoptotic marker) in renal and testicular tissues was diminished in the CIS group, while treatment with either free QUE or QUE.NPs ameliorated its expression (Figure 8 and Figure 9).